329 related articles for article (PubMed ID: 22906841)
21. Towards the use of nanoparticles in cancer therapy and imaging.
Pauwels EK; Erba P
Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
[TBL] [Abstract][Full Text] [Related]
22. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
23. Theranostic applications of nanoparticles in cancer.
Ahmed N; Fessi H; Elaissari A
Drug Discov Today; 2012 Sep; 17(17-18):928-34. PubMed ID: 22484464
[TBL] [Abstract][Full Text] [Related]
24. Nanotheranostics for personalized medicine.
Kim TH; Lee S; Chen X
Expert Rev Mol Diagn; 2013 Apr; 13(3):257-69. PubMed ID: 23570404
[TBL] [Abstract][Full Text] [Related]
25. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
[TBL] [Abstract][Full Text] [Related]
26. Small-molecule delivery by nanoparticles for anticancer therapy.
Chen ZG
Trends Mol Med; 2010 Dec; 16(12):594-602. PubMed ID: 20846905
[TBL] [Abstract][Full Text] [Related]
27. Protease-activated nanomaterials for targeted cancer theranostics.
Chan YC; Hsiao M
Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
[TBL] [Abstract][Full Text] [Related]
28. Silver nanoparticles in cancer: therapeutic efficacy and toxicity.
Ong C; Lim JZ; Ng CT; Li JJ; Yung LY; Bay BH
Curr Med Chem; 2013 Feb; 20(6):772-81. PubMed ID: 23298139
[TBL] [Abstract][Full Text] [Related]
29. Preparation of Multifunctional Nanoprobes for Tumor-Targeted Fluorescent Imaging and Therapy.
Zhou M; Xiao X; Kadi AA; Fun HK; Li J; Zhang Y
Curr Drug Targets; 2015; 16(6):549-59. PubMed ID: 25330033
[TBL] [Abstract][Full Text] [Related]
30. PRINT: a novel platform toward shape and size specific nanoparticle theranostics.
Perry JL; Herlihy KP; Napier ME; Desimone JM
Acc Chem Res; 2011 Oct; 44(10):990-8. PubMed ID: 21809808
[TBL] [Abstract][Full Text] [Related]
31. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
Zhu L; Mao H; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1793. PubMed ID: 35396932
[TBL] [Abstract][Full Text] [Related]
32. Nanotechnology for sensing, imaging, and treating cancer.
Panchapakesan B; Wickstrom E
Surg Oncol Clin N Am; 2007 Apr; 16(2):293-305. PubMed ID: 17560513
[TBL] [Abstract][Full Text] [Related]
33. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
Caldorera-Moore ME; Liechty WB; Peppas NA
Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
[TBL] [Abstract][Full Text] [Related]
34. Solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields.
Makino A; Kimura S
ScientificWorldJournal; 2014; 2014():424513. PubMed ID: 25379530
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
[TBL] [Abstract][Full Text] [Related]
36. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
Chen D; Dougherty CA; Zhu K; Hong H
J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
[TBL] [Abstract][Full Text] [Related]
37. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
38. Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy.
Luo S; Yang X; Shi C
Curr Med Chem; 2016; 23(5):483-97. PubMed ID: 26695513
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.
Zhang J; Wang L; You X; Xian T; Wu J; Pang J
Curr Top Med Chem; 2019; 19(1):57-73. PubMed ID: 30686255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
